.

Aerosmith's Deuces Are Wild Residency Tops $35 Million


Bruce Henne | 10-18-2019

Share on Facebook Share on Twitter Pin it Share on Reddit email this article

Aerosmith

[Updated] (hennemusic) Aerosmith's "Deuces Are Wild" residency in Las Vegas has topped the $35 million mark, according to a new report by Billboard.

The Boston band's series at the Park Theater at Park MGM has sold 163,820 tickets to deliver gross revenue of $35.6 million since its opening in April; with an average of $1.045 million per show, Aerosmith are helping set a new seven-figure standard in Las Vegas alongside 2019 residencies by Lady Gaga and Bruno Mars.
Aerosmith currently sit at No. 2 on the Billboard Hot Tours chart as the group's run of six shows from September 21 to October 6 grossed $6.5 million and sold 29,805 tickets.

The latest figures give Aerosmith a total touring gross of $514.9 million (from 9,208,421 tickets sold) to earn them the status as the 10th rock band in Billboard Boxscore history to cross the half-billion dollar threshold, joining Bon Jovi, Coldplay, Dave Matthews Band, Depeche Mode, Eagles, Guns N' Roses, Metallica, The Rolling Stones and U2. Read more and watch the official video highlights montage from opening night here.

Update: the original numbers reported were incorrect, they were actually higher and this story has been amended to include the correct numbers.

hennemusic is an official news provider for antiMusic.com.
Copyright hennemusic - Excerpted here with permission.


Related Stories
Aerosmith's Steven Tyler Blasted For National Anthem Performance On This Day In Rock 2012

Alice Cooper Not Following KISS and Aerosmith Into Retirement - 2023 In Review

Aerosmith Postponed Farewell Tour Due To Steven Tyler Injury - 2023 In Review

Aerosmith Aim To Resume Farewell Tour This Summer Or Fall

Aerosmith In The Studio For Get A Grip's 30th Anniversary - 2023 In Review

More Aerosmith News



advertisement

advertisement


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - Why we are antiMusic

Copyright© 1998 - 2023 Iconoclast Entertainment Group All rights reserved.